Latest news with #AEON
Associated Press
a day ago
- Business
- Associated Press
AEON Integrates TRON Network to Enable Seamless In-Store Payments
HONG KONG, June 9, 2025 /PRNewswire/ -- AEON, the next generation crypto framework built for payments, has integrated the TRON network to enable seamless in-store payments. Through AEON Pay, users can now transact using TRX, the native utility token of the TRON network. USDT and USDD on TRON for offline payments are also included to bring fast and low-cost digital payments into everyday retail experiences. This integration marks a major milestone in AEON's mission to make crypto spending frictionless and widely accessible, while significantly expanding the utility of TRON-based digital assets in global retail environments. As one of the most actively used public layer-1 blockchains, TRON's high throughput and low transaction fees have earned it a reputation for fast and secure payments. In addition to TRX, USDD and USDT on TRON can now be used to make purchases at thousands of physical retail locations. From global franchises to local stores, approximately 10,000 brands and 20 million merchants across Southeast Asia can now tap into a circulating supply of $77B+ stablecoins on TRON. Expansion into Africa and Latin America is currently in development. 'TRON encompasses a global community that has embraced blockchain as a fast, affordable, reliable, and stable means of transacting,' said AEON's CEO, Eddie Li. 'The sheer volume of users and stablecoin activity on their network is extremely well-suited to AEON's growing suite of payment services for users around the world.' To make purchases, users simply open the AEON Pay app, scan the merchant's QR code, and pay directly with their TRON-based digital assets. By tapping into TRON's expansive global user base, AEON is accelerating crypto adoption where it matters most: on the streets, in cafes, and at retail counters. 'AEON Pay's integration greatly enhances TRON's mission to become a global settlement layer,' said Sam Elfarra, Community Spokesperson for the TRON DAO. 'We each approach the goal of driving Web3 adoption by building bridges between crypto and traditional finance.' This strategic collaboration with TRON underscores AEON's leadership in real-world crypto payment innovation. As AEON continues to shape a globally connected Web3 economy, its support for TRON reaffirms its commitment to driving mass adoption of crypto and integrating it into everyday payment experiences. About AEON AEON is the next-generation crypto payment framework, built for AI to drive intelligent, automated payments across Web3 and simplify how crypto works in real life. With omni-chain support, AEON's AI Payments system allows intelligent agents to manage and automate transactions, payments, subscriptions, and remittances for users. With offerings like Web3 Mobile Payment that allows users to pay with crypto across 10,000 brands at 20+ million retail merchants in SEA, Africa and Latin America, Online Web3 Payment, Swap Pay, and a growing suite of AI-integrated payment services, AEON aims to create a future of crypto finance that's intelligent, scalable, and borderless, where AI meets real life through seamless, scalable payments for next billion of users. Website | X | Telegram | Medium About TRON DAO TRON DAO is a community-governed DAO dedicated to accelerating the decentralization of the internet via blockchain technology and dApps. Founded in September 2017 by H.E. Justin Sun, the TRON blockchain has experienced significant growth since its MainNet launch in May 2018. TRON hosts the largest circulating supply of USD Tether (USDT) stablecoin, exceeding $77.7 billion. As of June 2025, the TRON blockchain has recorded over 310 million in total user accounts, more than 10 billion in total transactions, and over $21.5 billion in total value locked (TVL), based on TRONSCAN. TRONNetwork | TRONDAO | X | YouTube | Telegram | Discord | Reddit | GitHub | Medium | Forum View original content: SOURCE AEON
Hype Malaysia
6 days ago
- Business
- Hype Malaysia
Smell Sea-sational With Issey Miyake's New Ocean-Inspired L'Eau D'Issey Fragrances
This is THE drop, perfume aficionados! Issey Miyake is making a splash this year with not one, but two new fragrances inspired by the raw beauty and rhythm of the ocean. Say hello to L'Eau D'Issey Eau De Parfum Intense and L'Eau D'Issey Pour Homme Eau De Parfum – bold, elegant, and irresistibly fresh, these scents invite you to dive into a whole new world of aquatic luxury. 'I wanted perfumers to see beneath the surface of the water, to feel what I feel,' says ocean explorer Alexis Rosenfeld, whose underwater adventures helped inspire this olfactory voyage. L'Eau D'Issey Eau De Parfum Intense Inspired by the ocean's beauty and movement, this luxurious fragrance by Amandine Clerc-Marie captures the hypnotic rhythm of the sea. Centred around a unique Posidonia (Neptune grass) accord, it blends aquatic, herbaceous, and floral notes. Rich ylang-ylang and damascena rose add depth, while natural vanilla infuses a warm, sensual finish – creating a scent that's both refreshing and deeply evocative. L'Eau D'Issey Pour Homme Eau De Parfum This ocean-inspired fragrance by Sophie Labbé is a luxurious blend of contrasts – fresh and warm, fluid and textured. It opens with vibrant Sichuan pepper and lemon essence, unveiling an aquatic heart, and settles into a deep, elegant base of balsam fir and sustainably sourced cedarwood. A powerful, enigmatic scent that captures the essence of the sea. Clean Beauty, Conscious Luxury Both L'Eau D'Issey Pour Homme Eau De Parfum and Eau D'Issey Eau De Parfum Intense crafted by Amandine Clerc-Marie and Sophie Labbé are 91% naturally derived ingredients, blending purity with sophistication. The fragrance is elevated by 100% natural alcohol, sourced exclusively from French beetroot, for a clean, refined essence that's as chic as it is conscious. The Issey Miyake fragrances are available in Parkson, Isetan, and AEON, Issey Miyake Lazada, and Zalora Official Store. What's your Reaction? +1 0 +1 0 +1 0 +1 0 +1 0 +1 0
New Indian Express
03-06-2025
- Business
- New Indian Express
India's longest U-girder installed at Ramapuram, near L&T headquarters
CHENNAI: CMRL has installed India's longest U-girder (33.33-metre-long) at Ramapuram as part of its Phase 2, Corridor 5 project, a release said. Executed in collaboration with General Consultant AEON and contractor L&T, the U-girder weighing 225 tonnes was attempted near L&T headquarters. The release stated that generally, they opted for the U-girder, which also turned out to be aesthetically 'excellent', according to CMRL. A total of six girders with 33.33 metres each were installed across three spans, with two per span. Transporting the massive girder from the casting yard to the site required detailed logistical planning and flawless coordination, the release said. It was done using specialised 6+6 axle multi-axle trailers powered by a Volvo FH 520 HP puller. 'The pioneering girder marks a significant engineering feat and a testament to the technical prowess, innovation,' CMRL said.
Emirates Woman
02-06-2025
- Business
- Emirates Woman
The skincare brand Noble Panacea partners with AEON Clinic
This month, the Nobel Laureate-founded luxury skincare brand Noble Panacea officially launches in the region through an exclusive partnership with AEON Clinic. The setting? In the Middle East's first and only Regenerative & Longevity Wellness Centre affiliated with the American Board of Regenerative Medicine, located in none other than Atlantis The Royal – one of Dubai's prestigious properties. THE PARTNERSHIP For Noble Panacea, this move is more than just a regional debut—it's a meeting of minds with a like-minded partner in high-tech healing. 'This collaboration reflects a perfect alignment of values, as both Noble Panacea and AEON share a commitment to cutting-edge technology, advanced skin expertise, and holistic approaches to longevity and optimal skin health,' says Audrey Bois Nicolaï, Co-Creator and Brand VP of Noble Panacea. 'Created by a Nobel Laureate, our brand brings a unique dimension of scientific innovation to complement AEON's state-of-the-art expertise… and this partnership offers them the ultimate fusion of innovation, technology, well-being, and indulgence. Together, we will deliver an unparalleled skincare experience that immerses clients in luxury while empowering skin health and longevity at the pinnacle of high-tech wellness.' For Dr. Jaffer Khan, Founder & Executive Chairman of AEON Clinic, the collaboration was organic on the outset: 'At AEON Clinic, our dedication to providing advanced regenerative aesthetic treatments aligns seamlessly with Noble Panacea's scientifically formulated products. By incorporating their exceptional solutions into our treatments, we are enhancing the results our clients experience, offering them the highest standard of rejuvenation and well-being,' he adds. To celebrate the partnership, an intimate media lunch was hosted, followed by an afternoon of insightful discussions and a personalised walkthrough at the AEON Clinic, giving guests a first look at what happens when cutting-edge skincare meets curated wellness. THE CLINIC Founded by renowned plastic surgeon Dr. Jaffer Khan, AEON Clinic is where regenerative medicine and cellular-level rejuvenation are a focus. The state-of-the-art clinic boasts age-defying technology and science-driven therapies, from exosome therapy, stem cell treatments, IV drips, and peptide programmes that rejuvenate and transform skin health– all delivered with aesthetic excellence. THE SKINCARE Created by Nobel Laureate Sir Fraser Stoddart, Noble Panacea's patented OSMV™ technology is the cornerstone of the brand, delivering active ingredients in a time-released, micro-dosed system across its five skincare collections, such as The Absolute, The Exceptional, The Elemental, The Brilliant, and The Energist. Meticulously created with efficacy and intelligence for maximum potency, the products are housed in a minimalist octagonal starch-based, refillable packaging. – For more on luxury lifestyle, news, fashion and beauty follow Emirates Woman on Facebook and Instagram Images: Supplied
Yahoo
23-05-2025
- Business
- Yahoo
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ('AEON' or the 'Company') (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, today reported the grant in May of 102,880 restricted stock units (RSUs) of the Company's common stock to newly hired non-executive employees of the company. The awards were approved by the Company's Board of Directors under the AEON 2025 Inducement Incentive Plan, which a grant date and vesting commencement date of May 21, 2025. The RSUs vest over four years, 25% on each annual anniversary of the vesting commencement date. The awards are subject to the terms and conditions of the Inducement Plan and the terms and conditions of the RSU agreement covering the grant. The awards are being granted as an inducement material to entering into employment with the Company in accordance with Section 711 of NYSE American LLC Company Guide. About AEON Biopharma AEON is a clinical stage biopharmaceutical company focused on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for debilitating medical conditions, with an initial focus on the neurosciences market. ABP-450 is the same botulinum toxin complex that is currently approved and marketed for cosmetic indications by Evolus under the name Jeuveau. ABP-450 is manufactured by Daewoong in compliance with current Good Manufacturing Practice, or cGMP, in a facility that has been approved by the U.S. Food and Drug Administration, Health Canada and European Medicines Agency. The product is approved as a biosimilar in Mexico and India. AEON has exclusive development and distribution rights for therapeutic indications of ABP-450 in the United States, Canada, the European Union, the United Kingdom, and certain other international territories. The Company has built a highly experienced management team with specific experience in biopharmaceutical and botulinum toxin development and commercialization. To learn more about AEON, visit Contacts Investor Contact: Corey Davis, Ph.D. LifeSci Advisors +1 212 915 2577 cdavis@ Source: AEON BiopharmaError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
